Log In
BCIQ
Print this Print this
 

xMAP NeoPlex4

  Manage Alerts
Collapse Summary General Information
Company Luminex Corp.
DescriptionPhenotypic screening assay to test newborn infants for congenital hyperthyroidism(CH), congenital adrenal hyperplasia (CAH) and cystic fibrosis (CF)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGenetic disorders, Diagnostic
Indication DetailsDiagnose congenital hypothyroidism (CH), congenital adrenal hyperplasia (CAH), and (CF) cystic fibrosis (phenotypic)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/18/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today